Articles, guides, and regulatory updates from our community.
New research from 34 countries shows how physical and social environments accelerate brain aging by up to 9-fold, affecting 18,701 participants.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's treatment, offering hope beyond traditional therapies with known safety profiles.
By Peptide Association Research Team
New research on mitochondria-targeted liposomes with SS-31 peptide demonstrates potential for enhancing thermogenesis in adipose tissue studies.
By Peptide Association Research Team
New research on carbonless amino acids reveals modified GHK peptides may have stronger metal binding properties. Study findings and clinical implications.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer antidiabetic drugs are generally cost-effective, though access varies by income level and drug pricing.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team
Systematic review of 142 studies reveals newer diabetes drugs show cost-effectiveness, but affordability varies by country income levels and treatment timing.
By Peptide Association Research Team
New research reveals how existing drugs like metformin and GLP-1 agonists may offer alternative approaches to Alzheimer's treatment through repurposing strategies.
By Peptide Association Research Team
Research reveals how mitochondria-targeted liposomes enhance thermogenesis in fat cells, offering potential obesity treatment through improved cellular metabolism.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's disease treatment, offering hope beyond current limited therapies.
By Peptide Association Research Team
New research reveals alarming connections between childhood obesity and cardiovascular disease. Study examines 381 million affected children worldwide.
By Peptide Association Research Team
Study reveals how spray-drying parameters affect injectable peptide suspension stability through advanced multimodal analysis techniques.
By Peptide Association Research Team
Recent research reveals 81% of newer antidiabetic drugs are cost-effective in developed countries, but accessibility remains limited in developing nations.
By Peptide Association Research Team
New research reveals how NAD+ may help restore brain function in Alzheimer's disease through REST protein modulation. Study findings and clinical implications.
By Peptide Association Research Team
New research across 34 countries reveals how physical and social environmental factors accelerate brain aging by up to 9-fold in both healthy individuals and those with dementia.
By Peptide Association Research Team
New research explores repurposing existing drugs for Alzheimer's treatment, highlighting mitochondrial-targeted therapies and multi-target approaches.
By Peptide Association Research Team
New research suggests IL-15 plus thymosin alpha-1 may help reverse T cell aging in liver cancer models. Learn about this promising peptide combination study.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team
Recent study reveals tirzepatide achieved 22.7% weight loss at 52 weeks using telehealth protocol. Learn clinical implications for peptide therapy providers.
By Peptide Association Research Team
New nanoencapsulation research reveals enhanced neuroprotection against brain injury. Learn implications for thymosin beta 4 injury treatment approaches.
By Peptide Association Research Team
New research reveals how thymosin alpha 1 immune modulation may help combat HIV latency through IL-15 pathway activation in laboratory studies.
By Peptide Association Research Team
New research reveals thymosin alpha 1 immune therapy combined with IL-15 may help reverse immune cell aging in hepatocellular carcinoma. Learn the implications.
By Peptide Association Research Team
New 2026 research explores thymosin alpha 1 immune effects on CD8 T cells. Learn what this study means for immune peptide therapy applications.
By Peptide Association Research Team
New research on SS-31 peptide reveals neuroprotective mechanisms in stroke models. Study findings on mitochondrial peptide therapy for brain health.
By Peptide Association Research Team
New research on SS-31 Elamipretide and NAC shows promising airway protection mechanisms. Learn implications for thymosin alpha 1 immune support therapy.
By Peptide Association Research Team
Breakthrough study reveals how natural compounds protect against cognitive decline through anti-inflammatory pathways. Learn implications for peptide therapy.
By Peptide Association Research Team
New research on retatrutide, a triple-agonist peptide therapy, demonstrates significant benefits for type 2 diabetes and obesity management in clinical studies.
By Peptide Association Research Team
New C. elegans study reveals Eleutheroside B's neuroprotective effects through autophagy and antioxidant mechanisms. Learn implications for peptide therapy.
By Peptide Association Research Team
Recent veterinary research on treating dry eye disease offers insights for peptide therapy providers. Find qualified doctors and learn about emerging treatments.
By Peptide Association Research Team
New study reveals safety concerns about peptides used for tendon repair and athletic enhancement. Critical insights for healthcare providers and patients.
By Peptide Association Research Team
Breakthrough research reveals enhanced bioavailability of peptide minerals through innovative encapsulation technology. Learn what this means for therapy.
By Peptide Association Research Team
Breakthrough study reveals SS-31 mitochondrial peptide therapy combined with NMN shows promise for sarcopenia treatment. Learn about NAD peptide therapy advances.
By Peptide Association Research Team
Groundbreaking study reveals how spray-drying optimization improves peptide suspension stability for therapeutic applications including tendon repair.
By Peptide Association Research Team
New research reveals stable peptide formulation methods for glatiramer acetate nanoparticles, advancing peptide therapy manufacturing and storage solutions.
By Peptide Association Research Team
New research examines cost-effectiveness of diabetes medications. Learn about peptide therapy regulation and safety considerations for healthcare providers.
By Peptide Association Research Team
Breakthrough study reveals self-assembling peptide hydrogels enhance nerve regeneration when combined with stem cells. Learn about this promising research.
By Peptide Association Research Team
Groundbreaking research reveals next-generation GLP-1 peptide therapies targeting multiple receptors for enhanced diabetes and obesity treatment outcomes.
By Peptide Association Research Team
Latest longevity peptide research explores probiotic connections to aging populations. Learn what this means for peptide therapy and clinical practice.
By Peptide Association Research Team
New research reveals how MAPK p38α inhibition overcomes FPR1 mutations affecting immune surveillance. Learn about peptide therapy implications.
By Peptide Association Research Team
Recent study reveals diammonium glycyrrhizinate and vitamin D3 combination may help treat pulmonary fibrosis through novel mechanisms. Learn about the research.
By Peptide Association Research Team
New FDA study reveals higher adverse events in compounded GLP-1 peptides vs commercial versions. Important safety insights for peptide therapy providers.
By Peptide Association Research Team
New study shows chitosan-polylysine particles create effective sustained-release system. Learn implications for peptide delivery and therapeutic applications.
By Peptide Association Research Team
New research on cepharanthine reveals potential for hepatocellular carcinoma treatment through Hippo-YAP pathway regulation. Learn about this natural compound's mechanisms.
By Peptide Association Research Team
Latest 2026 research reveals BPC-157's potential for joint repair, tendon healing, and pain management. Study findings, dosage insights, and clinical implications.
By Peptide Association Research Team
Latest 2026 study reveals BPC 157's dual role in preventing hemorrhage and thrombosis. Learn about dosage implications and clinical significance for providers.
By Peptide Association Research Team
How peptides like BPC-157, larazotide, and KPV are being studied for gastrointestinal conditions — from inflammatory bowel disease to intestinal barrier repair.
By Peptide Association Editorial Team
The GLP-1 revolution has rewritten the rules of obesity treatment. How incretin-based peptide therapies achieve what diet and exercise alone cannot — and what comes next.
By Peptide Association Editorial Team
A comprehensive safety guide covering side effects, drug interactions, quality concerns, and red flags — essential reading for anyone considering or currently using peptide therapy.
By Peptide Association Editorial Team
The regulatory landscape for compounded peptides has shifted dramatically. Here's what clinicians must understand about FDA enforcement, 503A/503B rules, and the bulk drug substance list.
By Peptide Association Editorial Team
An honest assessment of BPC-157 research — separating the extensive animal data from the limited human evidence, and what providers should tell patients asking about this popular peptide.
By Peptide Association Editorial Team
How to evaluate compounding pharmacies, understand USP standards, interpret certificates of analysis, and ensure your patients receive safe, accurately dosed peptide products.
By Peptide Association Editorial Team
How the copper-binding tripeptide GHK-Cu influences wound healing, collagen synthesis, and gene expression — and what the evidence says about its anti-aging potential.
By Peptide Association Editorial Team
How mitochondrial-derived peptides like MOTS-c and humanin intersect with NAD+ biology to influence aging, metabolic health, and cellular resilience.
By Peptide Association Editorial Team
A head-to-head comparison of the two leading GLP-1 receptor agonists — mechanisms of action, clinical trial data, side effects, and practical considerations for providers and patients.
By Peptide Association Editorial Team
How CJC-1295, ipamorelin, tesamorelin, and other GH secretagogues work — the physiology, clinical evidence, and practical protocols for growth hormone optimization.
By Peptide Association Editorial Team
A deep dive into thymosin alpha-1 — the endogenous thymic peptide with decades of clinical research supporting its role in immune modulation, viral infections, and as an immunotherapy adjunct.
By Peptide Association Editorial Team
Everything you need to know about peptide therapy — from the science behind short-chain amino acids to clinical applications, delivery methods, and how to find a qualified provider.
By Peptide Association Editorial Team
How bremelanotide (PT-141) works through melanocortin receptors to address hypoactive sexual desire disorder — mechanism, clinical data, and practical prescribing considerations.
By Peptide Association Editorial Team
How peptides like DSIP, epitalon, and GH secretagogues can support sleep architecture, recovery, and circadian health — the evidence and practical protocols.
By Peptide Association Editorial Team